Sam Salek

10.7k total citations · 3 hit papers
228 papers, 6.8k citations indexed

About

Sam Salek is a scholar working on Economics and Econometrics, Dermatology and Immunology. According to data from OpenAlex, Sam Salek has authored 228 papers receiving a total of 6.8k indexed citations (citations by other indexed papers that have themselves been cited), including 95 papers in Economics and Econometrics, 40 papers in Dermatology and 37 papers in Immunology. Recurrent topics in Sam Salek's work include Health Systems, Economic Evaluations, Quality of Life (75 papers), Pharmaceutical Economics and Policy (53 papers) and Dermatology and Skin Diseases (35 papers). Sam Salek is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (75 papers), Pharmaceutical Economics and Policy (53 papers) and Dermatology and Skin Diseases (35 papers). Sam Salek collaborates with scholars based in United Kingdom, Italy and Germany. Sam Salek's co-authors include A.Y. Finlay, M.K.A. Basra, Stuart Walker, Yan HongBo, Michael Harrison, Charles L. Thomas, Ruben Gatt, Ghazala Khan, D K Luscombe and Faraz M Ali and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Sam Salek

210 papers receiving 6.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Translating the Science of Quality of Life into Practice: What Do Dermatology Life Quality Index Scores Mean?

2005 635 citations Sam Salek, A.Y. Finlay et al. profile →
The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results

2008 621 citations Sam Salek, A.Y. Finlay et al. British Journal of Dermatology profile →
The Psychological Burden of Skin Diseases: A Cross-Sectional Multicenter Study among Dermatological Out-Patients in 13 European Countries

2014 612 citations Dennis Linder, Francesca Sampogna et al. profile →

Peers

Countries citing papers authored by Sam Salek

Since Specialization

Citations

This map shows the geographic impact of Sam Salek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sam Salek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sam Salek more than expected).

Fields of papers citing papers by Sam Salek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sam Salek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sam Salek. The network helps show where Sam Salek may publish in the future.

Co-authorship network of co-authors of Sam Salek

This figure shows the co-authorship network connecting the top 25 collaborators of Sam Salek. A scholar is included among the top collaborators of Sam Salek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sam Salek. Sam Salek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Impact of leukemia subtype and demographics on patient quality of life in 76 countries: a cross-sectional study 2025 ·SHILAP Revista de lepidopterología ·Sam Salek, (unknown), (unknown), Tatyana Ionova, (unknown), Giovanni Tripepi, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Esther Natalie Olíva	0
2	Cancer Therapy-Induced Cardiotoxicity: Results of the Analysis of the UK DEFINE Database 2025 ·Cancers ·(unknown), R Fitzpatrick, Deborah Layton, (unknown), Sam Salek	1
3	Evaluation of good review practices in member authorities of the East African Medicines Regulatory Harmonisation initiative: strategies for alignment with African medicines agency 2024 ·Frontiers in Medicine ·(unknown), Margareth Ndomondo-Sigonda, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Stuart Walker, Sam Salek	2
4	Cancer-Therapy-Induced Cardiotoxicity: Results of the Analysis of the UK Yellow Card Adverse Drug Reaction (ADR) Reporting 2024 ·Cancers ·(unknown), Deborah Layton, (unknown), Sam Salek	0
5	P047 Dermatology Life Quality Index used as a standard in validation of 101 quality-of-life instruments: a systematic review 2024 ·British Journal of Dermatology ·Jui Vyas, Jeffrey Johns, (unknown), Faraz M Ali, John R Ingram, Sam Salek, A.Y. Finlay	0
6	Development of a Consumer Reported Outcome Measure for Personal Care Products : The Rationale 2024 ·International Journal of Scientific Research in Science and Technology ·Robert E. Falcone, (unknown), Bozena Michniak‐Kohn, Sam Salek	1
7	Comparison of the impact of type 1 and type 2 diabetes on quality of life of families of patients: A UK cross‐sectional study 2024 ·Diabetes Obesity and Metabolism ·(unknown), A.Y. Finlay, Faraz M Ali, Kennedy Otwombe, S J Nixon, Lindsay George, Marc Evans, John R Ingram, Sam Salek	1
8	Measurement of the major ignored burden of multiple myeloma, pernicious anaemia and of other haematological conditions on partners and family members: A cross‐sectional study 2024 ·European Journal Of Haematology ·(unknown), A.Y. Finlay, Faraz M Ali, Harris Allen, S J Nixon, Mark Nixon, Kennedy Otwombe, John R Ingram, Sam Salek	4
9	Longitudinal validity of the Hyperhidrosis Quality of Life Index (HidroQoL©) in a phase IIIb clinical trial population with hyperhidrosis: responsiveness and meaningful change 2024 ·British Journal of Dermatology ·(unknown), (unknown), Clarissa Masur, Paul Kamudoni, Sam Salek, Christoph Abels, Christian Apfelbacher	0
10	Regional regulatory harmonisation initiatives: Their potential contribution to the newly established African Medicines Agency 2023 ·Regulatory Toxicology and Pharmacology ·(unknown), Margareth Ndomondo-Sigonda, Stuart Walker, Sam Salek	3
11	A cross‐sectional study of the prevalence and clinical management of atherosclerotic cardiovascular diseases in patients with type 2 diabetes across the Middle East and Africa ( PACT‐MEA ): Study design and rationale 2023 ·Diabetes Obesity and Metabolism ·Subodh Verma, Hani Sabbour, Naji Alamuddin, Fatheya Alawadi, Hessa Alkandari, Wael Almahmeed, Samir H. Assaad‐Khalil, (unknown), (unknown), Rayaz A. Malik, (unknown), Preethy Prasad, (unknown), Sam Salek	8
12	Meaning of Family Reported Outcome Measure (FROM-16) severity score bands: a cross-sectional online study in the UK 2023 ·BMJ Open ·(unknown), A.Y. Finlay, Sam Salek, (unknown), Kennedy Otwombe, Faraz M Ali, John R Ingram	8
13	Impact of European Union Label Changes for Fluoroquinolone-Containing Medicinal Products for Systemic and Inhalation Use: Post-Referral Prescribing Trends 2023 ·Drug Safety ·(unknown), (unknown), Thom S. Lysen, (unknown), Hanne van Ballegooijen, Peter Rijnbeek, Talita Duarte‐Salles, Carlen Reyes, Luis H. John, Leila Karimi, Christian Reich, Sam Salek, Deborah Layton	14
14	What do Hyperhidrosis Quality of Life Index (HidroQoL©) scores mean? Transferring science into practice by establishing a score banding system 2023 ·British Journal of Dermatology ·(unknown), (unknown), (unknown), Clarissa Masur, Paul Kamudoni, Sam Salek, Christoph Abels, Christian Apfelbacher	1
15	Psychometric validation of the Pyruvate Kinase Deficiency Diary and Pyruvate Kinase Deficiency Impact Assessment in adults in the phase 3 ACTIVATE trial 2023 ·Journal of Patient-Reported Outcomes ·David Andrae, Rachael F. Grace, (unknown), (unknown), Robert J. Klaassen, Sam Salek, Junlong Li, Feng Tai, Audra Boscoe, Erin Zagadailov	0
16	Biosimilar development and review process in the BRICS-TM countries: Proposal for a standardized model to improve regulatory performance 2022 ·Expert Review of Clinical Pharmacology ·(unknown), (unknown), Sam Salek	3
17	Challenges Faced by the Biopharmaceutical Industry in the Development and Marketing Authorization of Biosimilar Medicines in BRICS-TM Countries: An Exploratory Study 2021 ·Pharmaceutical Medicine ·(unknown), (unknown), (unknown), (unknown), Sam Salek	16
18	Quality of life assessment in core outcome sets: A position statement of the EADV Task Force on Quality of Life and Patient Oriented Outcomes 2021 ·Journal of the European Academy of Dermatology and Venereology ·Pavel V. Chernyshov, Andrea W.M. Evers, Anthony Bewley, L. Tomás-Aragonés, S.E. Marrón, L. Manolache, Nives Pustišek, Damiano Abeni, Francesca Sampogna, Dennis Linder, Sam Salek, Jacek C. Szepietowski	7
19	Quality of life measurement in occupational skin diseases. Position paper of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient Oriented Outcomes and Occupational Skin Disease 2020 ·Journal of the European Academy of Dermatology and Venereology ·Pavel V. Chernyshov, Swen Malte John, L. Tomás-Aragonés, Margarida Gonçalo, Åke Svensson, Anthony Bewley, Andrea W.M. Evers, Jacek C. Szepietowski, S.E. Marrón, L. Manolache, Nives Pustišek, (unknown), Carmen Sălăvăstru, George‐Sorin Ţiplica, Sam Salek, A.Y. Finlay	13
20	Quality-of-Life Assessment in Patients on Peritoneal Dialysis: A Review of the State of the Art 1996 ·Peritoneal Dialysis International ·Sam Salek	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact